Upgrade to SI Premium - Free Trial

BTIG Reiterates Buy Rating on Caris Life Sciences Inc (CAI)

July 2, 2026 6:16 AM
BTIG analyst Mark Massaro reiterated a Buy rating and $32.00 price target on Caris Life Sciences Inc (NASDAQ: CAI).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments